Purine metabolism in women with primary gout. 1994

J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
La Paz University Hospital, Division of Internal Medicine, Madrid, Spain.

OBJECTIVE Uncontrolled studies have shown that women with gout have higher serum urate concentrations and similar or lower urinary uric acid excretion rates than do men with gout. These observations suggest a more defective tubular transport of uric acid in women than in men with gout. In this prospective study we assessed purine metabolism in women with primary gout under controlled conditions. We also examined whether there are sex-related differences in plasma and urinary purine concentrations among patients with primary gout. METHODS Ten women with crystal-proved primary gout and normal serum creatinine levels (below 116 mmol/L) were studied while they were on a purine-restricted diet and taking no medications known to influence uric acid metabolism. For comparison, 20 men with primary gout and 10 women without gout, matched for age, race, and body mass index, were studied under the same conditions. In each subject, plasma and 24-hour urinary uric acid, hypoxanthine, and xanthine concentrations were measured. The mean of three consecutive determinations for plasma purines and five for urinary purines was used. Standard formulas were used to calculate the renal clearances and the fractional excretion of purines. RESULTS Mean plasma urate, hypoxanthine, and xanthine levels were significantly higher in women patients with primary gout compared with normal women (P < 0.05). Mean 24-hour urinary uric acid excretion was similar in both groups. Daily urinary hypoxanthine and xanthine excretion rates were significantly lower in gouty women patients than in control women (P < 0.05). The renal clearances and the fractional excretion of uric acid, hypoxanthine, and xanthine were markedly lower in women with primary gout than in control women (P < 0.05). Plasma and urinary purine concentrations were similarly increased and diminished, respectively, in women and men patients with primary gout. Plasma urate, hypoxanthine, and xanthine levels were inversely and significantly associated with the fractional excretion of uric acid (r = -0.520; P = 0.003), hypoxanthine (r = -0.555; P = 0.002), and xanthine (r = -0.384; P = 0.040), respectively. CONCLUSIONS Women with primary gout have markedly diminished uric acid, hypoxanthine, and xanthine excretion rates. The disturbance of purine metabolism appears to be of a similar magnitude to that observed in gouty men. The absence of significant sex-related differences in plasma and urinary purine concentrations suggests a similar tubular dysfunction for purine excretion in women and men with primary gout.

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
January 1952, Advances in internal medicine,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
August 1962, The Journal of the Kansas Medical Society,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
February 1993, Pediatric nephrology (Berlin, Germany),
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
July 1968, The Journal of clinical investigation,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
May 1957, Metabolism: clinical and experimental,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
November 1975, The Journal of clinical investigation,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
October 1985, Revista clinica espanola,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
February 1968, Lakartidningen,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
March 1978, Clinical and experimental immunology,
J G Puig, and F A Mateos, and M E Miranda, and R J Torres, and E de Miguel, and C Pérez de Ayala, and A A Gil
November 1972, Klinische Wochenschrift,
Copied contents to your clipboard!